Cargando…

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

BACKGROUND: Taspase 1 (TASP1) is a highly conserved protease involved in site-specific proteolysis. Existing researches have revealed a link between TASP1 expression and carcinogenesis. However, limited data are available regarding the prognosis and functions of TASP1 in hepatocellular carcinoma (HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jie, Liu, Bin, Liu, Ruilin, Yang, Wenzhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981154/
https://www.ncbi.nlm.nih.gov/pubmed/33758547
http://dx.doi.org/10.2147/CMAR.S296069
_version_ 1783667501044858880
author Jiang, Jie
Liu, Bin
Liu, Ruilin
Yang, Wenzhuo
author_facet Jiang, Jie
Liu, Bin
Liu, Ruilin
Yang, Wenzhuo
author_sort Jiang, Jie
collection PubMed
description BACKGROUND: Taspase 1 (TASP1) is a highly conserved protease involved in site-specific proteolysis. Existing researches have revealed a link between TASP1 expression and carcinogenesis. However, limited data are available regarding the prognosis and functions of TASP1 in hepatocellular carcinoma (HCC). METHODS: Western Blotting and qRT-PCR were employed to evaluate the level of TASP1 in HCC cell lines and clinical specimens. TASP1 expression was further calculated in clinical specimens by immunohistochemistry and the mRNA level of TASP1 in HCC was analyzed using Oncomine and UALCAN databases. The TASP1 promoter methylation modification was shown via MEXPRESS and UALCAN. The association between TASP1 expression and postoperative prognosis was evaluated using Kaplan–Meier and Cox regression analysis in clinical patients. The effect of TASP1 on HCC prognosis was analyzed via Kaplan-Meier plotter, GEPIA and UALCAN. Additionally, the regulators, kinases, miRNA and transcription factor targets of TASP1 were identified using LinkedOmics. Moreover, cBioPortal was used to detect the genetic alteration of TASP1. Finally, TIMER was utilized to assess the relation between TASP1 and the immune cell infiltration, whereas the correlation of TASP1 with three immune factors was detected through TISIDB. RESULTS: TASP1 expression was increased in HCC cell lines and HCC tissues. CNV and DNA methylation of TASP1 were changed. Survival analysis revealed that high TASP1 expression was correlated with overall survival (OS). Functional network analysis about TASP1 in HCC showed that the double-strand break repair, peptidyl-threonine modification, spindle organization, peptidyl-lysine modification and microtubule-based movement were modulated. Furthermore, TASP1 expression revealed puissant relation to the infiltration of immune cells and three immune factors in HCC. CONCLUSION: These data indicate that TASP1 may act as a potential prognostic marker in HCC and regulate HCC via multiple mechanisms.
format Online
Article
Text
id pubmed-7981154
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-79811542021-03-22 Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma Jiang, Jie Liu, Bin Liu, Ruilin Yang, Wenzhuo Cancer Manag Res Original Research BACKGROUND: Taspase 1 (TASP1) is a highly conserved protease involved in site-specific proteolysis. Existing researches have revealed a link between TASP1 expression and carcinogenesis. However, limited data are available regarding the prognosis and functions of TASP1 in hepatocellular carcinoma (HCC). METHODS: Western Blotting and qRT-PCR were employed to evaluate the level of TASP1 in HCC cell lines and clinical specimens. TASP1 expression was further calculated in clinical specimens by immunohistochemistry and the mRNA level of TASP1 in HCC was analyzed using Oncomine and UALCAN databases. The TASP1 promoter methylation modification was shown via MEXPRESS and UALCAN. The association between TASP1 expression and postoperative prognosis was evaluated using Kaplan–Meier and Cox regression analysis in clinical patients. The effect of TASP1 on HCC prognosis was analyzed via Kaplan-Meier plotter, GEPIA and UALCAN. Additionally, the regulators, kinases, miRNA and transcription factor targets of TASP1 were identified using LinkedOmics. Moreover, cBioPortal was used to detect the genetic alteration of TASP1. Finally, TIMER was utilized to assess the relation between TASP1 and the immune cell infiltration, whereas the correlation of TASP1 with three immune factors was detected through TISIDB. RESULTS: TASP1 expression was increased in HCC cell lines and HCC tissues. CNV and DNA methylation of TASP1 were changed. Survival analysis revealed that high TASP1 expression was correlated with overall survival (OS). Functional network analysis about TASP1 in HCC showed that the double-strand break repair, peptidyl-threonine modification, spindle organization, peptidyl-lysine modification and microtubule-based movement were modulated. Furthermore, TASP1 expression revealed puissant relation to the infiltration of immune cells and three immune factors in HCC. CONCLUSION: These data indicate that TASP1 may act as a potential prognostic marker in HCC and regulate HCC via multiple mechanisms. Dove 2021-03-16 /pmc/articles/PMC7981154/ /pubmed/33758547 http://dx.doi.org/10.2147/CMAR.S296069 Text en © 2021 Jiang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jiang, Jie
Liu, Bin
Liu, Ruilin
Yang, Wenzhuo
Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
title Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
title_full Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
title_fullStr Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
title_full_unstemmed Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
title_short Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
title_sort overexpression of taspase 1 predicts poor prognosis in patients with hepatocellular carcinoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981154/
https://www.ncbi.nlm.nih.gov/pubmed/33758547
http://dx.doi.org/10.2147/CMAR.S296069
work_keys_str_mv AT jiangjie overexpressionoftaspase1predictspoorprognosisinpatientswithhepatocellularcarcinoma
AT liubin overexpressionoftaspase1predictspoorprognosisinpatientswithhepatocellularcarcinoma
AT liuruilin overexpressionoftaspase1predictspoorprognosisinpatientswithhepatocellularcarcinoma
AT yangwenzhuo overexpressionoftaspase1predictspoorprognosisinpatientswithhepatocellularcarcinoma